Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +14.20%
#3 eCash eCash +9.92%
#4 OPENLOOT OPENLOOT +8.47%
#5 Fake World Assets Fake World Assets +8.42%
#6 Ergo Ergo +7.75%
#7 Verus Coin Verus Coin +7.73%
#8 Meteora Meteora +7.31%
#9 Unit Pump Unit Pump +7.21%
#10 Pump.fun Pump.fun +7.21%
Coin of the day
PulseChain PulseChain
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Classifica tra le azioni #28164
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Prezzo delle azioni
$0.5495
Ultima sincronizzazione: 2025-05-15
Capitalizzazione di mercato
$28.14M
Variazione (1 giorno)
4.70%
Variazione (1 anno)
0.00%
Paese
US
Scambia Enzo Biochem, Inc. (ENZ)

Categoria

Healthcare
Ricavi di Enzo Biochem, Inc. (ENZ)
Ricavi nel Apr 2025 TTM: $27.48M
Secondo gli ultimi rapporti finanziari di Enzo Biochem, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $27.48M. Nel 2023, l'azienda ha registrato ricavi di $31.06M una diminuzione rispetto a i ricavi dell'anno 2022, che erano pari a $107.07M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Enzo Biochem, Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $27.48M -13.89%
2024 $31.91M 2.72%
2023 $31.06M -70.99%
2022 $107.07M -9.05%
2021 $117.73M 54.87%
2020 $76.02M -6.34%
2019 $81.17M -22.48%
2018 $104.71M -2.87%
2017 $107.80M 4.90%
2016 $102.77M 5.30%
2015 $97.60M 1.72%
2014 $95.95M 2.39%
2013 $93.71M -9.10%
2012 $103.08M 1.03%
2011 $102.03M 5.10%
2010 $97.08M 8.38%
2009 $89.57M 15.14%
2008 $77.80M 47.04%
2007 $52.91M 32.85%
2006 $39.83M -8.24%
2005 $43.40M 4.22%
2004 $41.64M -21.08%
2003 $52.77M -2.31%
2002 $54.02M -7.52%
2001 $58.41M 16.75%
2000 $50.03M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B 168,547.86%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B 91,281.26%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B 9,752.87%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B 16,472.24%
US